Home » Topics » Regulatory

Regulatory
RSS

Unimed granted patent coverage for dronabinol use as dementia therapy

June 5, 1998

FDA approves new combination therapy product for HCV

June 4, 1998

Novartis files for U.S. marketing approval of Sandostatin LAR

June 3, 1998

FDA advisory committee recommends expanded use of Taxotere

June 2, 1998

FDA approves Aggrastat, the first platelet blocker for unstable angina

May 22, 1998

Cor's fibrinogen antagonist on the way to market

May 19, 1998

Sanofi receives expanded approval for oxaliplatin in France

May 15, 1998

Actiq trial results published; NDA amendment filed

May 11, 1998

Serono introduces Geref for treatment/diagnosis of GHD

May 8, 1998

FDA approves improved oral contraceptive agent

May 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.